Literature DB >> 985377

Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.

S D Skaper, D P Molden, J E Seegmiller.   

Abstract

The intracellular concentration of free leucine, isoleucine, and valine and their metabolism were studied in lymphoblast cultures established from peripheral blood of an individual with maple syrup urine disease (MSUD) and a control subject. Branched-chain alpha-keto acid decarboxylase activity in the MSUD cells was 10% or less of the control value as measured by the ability of the cells to release 14CO2 from the corresponding [1-14C]labeled branched-chain amino acid. The intracellular concentrations of free leucine and isoleucine were increased three-fold in MSUD lymphoblasts as compared to control cells. Free valine was present in only trace amounts of less than 0.1 mM in both cell lines. Exposure of normal and mutant cells to a 10 mM load of leucine, isoleucine, and valine revealed in a comparable concentration within cells after 24 hr. Concentrations returned to base values in normal cells 12 hr after removal of load, but leucine remained elevated in MSUD cells after 3 days. Leucine and its keto acid, alpha-ketoisocaproic acid, added to the culture medium gave significant growth inhibition of MSUD lymphoblasts but not of normal cells, in the millimolar range. Isoleucine, valine, and their keto acids had no effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 985377     DOI: 10.1007/bf00485832

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  30 in total

1.  THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.

Authors:  J DANCIS; J HUTZLER; M LEVITZ
Journal:  Pediatrics       Date:  1963-08       Impact factor: 7.124

2.  CEREBRAL LIPIDS IN MAPLE SYRUP DISEASE.

Authors:  J H MENKES; M PHILIPPART; R E FIOL
Journal:  J Pediatr       Date:  1965-03       Impact factor: 4.406

3.  Studies in maple syrup urine disease.

Authors:  C E DENT; R G WESTALL
Journal:  Arch Dis Child       Date:  1961-06       Impact factor: 3.791

4.  Maple syrup urine disease.

Authors:  J DANCIS; M LEVITZ; S MILLER; R G WESTALL
Journal:  Br Med J       Date:  1959-01-10

5.  Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria.

Authors:  R E TASHIAN
Journal:  Metabolism       Date:  1961-05       Impact factor: 8.694

6.  Maple syrup urine disease: branched-chain keto-aciduria.

Authors:  J DANCIS; M LEVITZ; R G WESTALL
Journal:  Pediatrics       Date:  1960-01       Impact factor: 7.124

7.  Maple syrup urine disease metabolites studies in cerebellum cultures.

Authors:  D H Silberberg
Journal:  J Neurochem       Date:  1969-07       Impact factor: 5.372

8.  Inhibition of brain protein synthesis: an approach to the biochemical basis of neurological dysfunction in the amino-acidurias.

Authors:  S H Appel
Journal:  Trans N Y Acad Sci       Date:  1966-11

9.  The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).

Authors:  J E Seegmiller; R G Westall
Journal:  J Ment Defic Res       Date:  1967-12

10.  Biochemically marked lymphocytoid lines: establishment of Lesch-Nyhan cells.

Authors:  K W Choi; A D Bloom
Journal:  Science       Date:  1970-10-02       Impact factor: 47.728

View more
  11 in total

1.  On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.

Authors:  P Schadewaldt; H W Hammen; C Dalle-Feste; U Wendel
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Complementation analysis in lymphoid cells from five patients with different forms of maple syrup urine disease.

Authors:  Y Jinno; I Akaboshi; I Matsuda
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  The diagnosis and management of MSUD in Saudi Arabia by using two different methods.

Authors:  S B Subramanyam; S M Qadri; M B Dhalla; P T Ozand
Journal:  Indian J Pediatr       Date:  1990 Sep-Oct       Impact factor: 1.967

4.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.

Authors:  P Jouvet; P Rustin; D L Taylor; J M Pocock; U Felderhoff-Mueser; N D Mazarakis; C Sarraf; U Joashi; M Kozma; K Greenwood; A D Edwards; H Mehmet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

5.  Study on established lymphoid cells in maple syrup urine disease. Correlation with clinical heterogeneity.

Authors:  Y Jinno; I Akaboshi; T Katsuki; I Matsuda
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.

Authors:  Y Indo; A Kitano; F Endo; I Akaboshi; I Matsuda
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

7.  Branched-chain ketoacid dehydrogenase activity and growth of normal and mutant human fibroblasts: the effect of branched-chain amino acid concentration in culture medium.

Authors:  D J Danner; J H Priest
Journal:  Biochem Genet       Date:  1983-10       Impact factor: 1.890

8.  Transamination of glutamate to tricarboxylic acid-cycle intermediates in cultured neurons correlates with the ability of oxo acids to support neuronal survival in vitro.

Authors:  L Facci; S D Skaper; S Varon
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

9.  Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses.

Authors:  Duale Ahmed; Allison Jaworski; David Roy; William Willmore; Ashkan Golshani; Edana Cassol
Journal:  Mediators Inflamm       Date:  2018-07-25       Impact factor: 4.711

Review 10.  The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids.

Authors:  Joris H J van Sadelhoff; Paula Perez Pardo; Jiangbo Wu; Johan Garssen; Jeroen van Bergenhenegouwen; Astrid Hogenkamp; Anita Hartog; Aletta D Kraneveld
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.